FASTHEADLINENEWS

$DNLI Headlines

7 trading headlines for $DNLI

Mar 26 05:46 PM

Morgan Stanley Maintains Overweight on Denali Therapeutics, Raises Price Target to $42

analystAlpaca

Mar 26 03:37 PM

Goldman Sachs Maintains Buy on Denali Therapeutics, Raises Price Target to $40

analystAlpaca

Mar 26 02:36 PM

Stifel Maintains Buy on Denali Therapeutics, Raises Price Target to $41

analystAlpaca

Mar 26 12:30 PM

FDA Clears Denali Therapeutics Drug As First Brain-Penetrating Biologic For Rare Disease

fdaAlpaca

Mar 26 11:51 AM

Baird Maintains Outperform on Denali Therapeutics, Raises Price Target to $32

analystAlpaca

Mar 26 11:37 AM

HC Wainwright & Co. Maintains Buy on Denali Therapeutics, Raises Price Target to $42

analystAlpaca

Mar 25 03:48 PM

FDA Approves Denali Therapeutics' Avlayah To Treat Hunter Syndrome

fdaAlpaca